As the COVID-19 continues to spread, our thoughts go out to everyone who has been infected or impacted. We hope that you, your family, friends and colleagues are safe and well, and are taking the necessary precautions to keep it that way.
Senseonics is continuously monitoring the situation for potential impacts related to the coronavirus. There is currently no change to product supply due to the COVID-19. We recognize additional precautionary measures are being implemented at healthcare provider offices which may impact your new Eversense sensor insertion and removal. We recommend calling your healthcare provider to confirm any appointments you may have for Eversense procedures before going into the office. The entire Eversense Customer Care team is here to work with you regarding any concerns or questions.
We are committed to helping our Eversense family navigate through this time of uncertainty. During this time of social distancing, we are only a phone call away to support your needs. We can assist you with:
- Qualifying for the Patient Access Program (if you’re new to Eversense)
- Working with your insurance company to appeal any denials
- Helping you with any questions or how to better use Eversense CGM to meet your diabetes management goals
On behalf of the Eversense team, it is a privilege be a part of your diabetes management program. Please stay safe, and as always, thank you for trusting Eversense.
Sincerely,
Fran Kaufman
Francine R. Kaufman, M.D.
Chief Medical Officer, Senseonics, Inc.
Distinguished Professor Emerita of Pediatrics
Keck School of Medicine of the University of Southern California
Children’s Hospital Los Angeles